Celgene Corporation Contingent Value Rights
CELGZ
CELGZ was delisted on the 29th of November, 2019.
24 hedge funds and large institutions have $1.47M invested in Celgene Corporation Contingent Value Rights in 2015 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 3 closing their positions.
4% less funds holding
Funds holding: 25 → 24 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
45% less capital invested
Capital invested by funds: $2.68M → $1.47M (-$1.2M)
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$18K |
| 2 |
MC
Muhlenkamp & Co
Wexford,
Pennsylvania
|
+$2.23K |
| 3 |
JP Morgan Chase
New York
|
+$122 |
| 4 |
Creative Planning
Overland Park,
Kansas
|
+$75 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$27 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$547K |
| 2 |
Millennium Management
New York
|
-$57.7K |
| 3 |
First Manhattan
New York
|
-$51.9K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$19K |
| 5 |
WJA
Williams Jones & Associates
New York
|
-$19K |
CELGZ Hedge Fund Activity: Q4 2015 in Review
24 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Celgene Corporation Contingent Value Rights (CELGZ) for Q4 2015, worth a combined $1.47M — down 45% from $2.68M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CELGZ and 2 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 3 added.
The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $18K. The largest seller was Opaleye Management, exiting entirely with an estimated $547K sold.
- 24 institutional investors held Celgene Corporation Contingent Value Rights (CELGZ) as of Q4 2015, down from 25 in Q3 2015.
- Funds reported $1.47M of Celgene Corporation Contingent Value Rights stock for Q4 2015, down 45% quarter-over-quarter.
- 2 funds opened new Celgene Corporation Contingent Value Rights positions in Q4 2015 and 3 closed out, a net change of -1 holder.
- The largest Celgene Corporation Contingent Value Rights buyer in Q4 2015 was Virtu KCG Holdings, an estimated $18K added.
- The largest Celgene Corporation Contingent Value Rights seller in Q4 2015 was Opaleye Management, an estimated $547K sold.
Based on aggregated 13F filings for Q4 2015.